Wound Care News and Research

RSS

Special Ops medics training at Virginia Commonwealth University Medical Center

They call themselves quiet professionals -- an elite, highly trained group of military experts known for their strength, stealth and speed. Some of their training is coming from doctors and nurses at the Virginia Commonwealth University Medical Center.

15 Jun 2004

Bone repair using breakthrough material

A breakthrough in polymer development means that soon there may be a radical new treatment for people with broken bones - a special kind of material that can 'glue' the bone back together and support it while it heals. The polmer material is designed to break down as the bone regrows leaving only natural tissue.

20 May 2004

PPD, Inc. has announced the launch of PPD Medical Device Division

PPD, Inc. has announced the launch of PPD Medical Device, a division of PPD Development, providing services to the medical device industry with experience in developing stents, devices and therapies in the areas of interventional cardiology, endovascular, neurology and orthopedic disorders as well as wound care.

10 May 2004

Biological bandages are being successfully used to treat patients with severe burns

Doctors have been impressed with the rapid recovery rates instigated by the ‘tailor-made ’ discs, which have been devised by a research team at the Sheffield company, CellTran, with financial support from the Wellcome Trust biomedical research charity and the White Rose Technology Seedcorn Fund. They will be officially launched at the British Burn Association’s annual meeting in Manchester tomorrow (28th).

27 Apr 2004

Coronary stent drives Johnson & Johnson to record profits

Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.

13 Apr 2004

LAM Pharmaceutical receives approval to sell it's wound gel in China

LAM Pharmaceutical, a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that the Chinese State Food and Drug Administration ("SFDA") has granted approval for the importation and sale of its patented LAM IPM Wound Gel(TM) in China

24 Mar 2004